4-acetyl-3-methyl-7-[[(4R,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]amino]-1H-naphthalen-2-one
C19H23NO7 — CID 158052492
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-acetyl-3-methyl-7-[[(4R,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]amino]-1H-naphthalen-2-one
4-acetyl-3-methyl-7-[[(4R,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]amino]-1H-naphthalen-2-one (PubChem CID 158052492) has the molecular formula C19H23NO7 and a molecular weight of 377.39 g/mol. Its IUPAC name is 4-acetyl-3-methyl-7-[[(4R,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]amino]-1H-naphthalen-2-one.
Molecular Properties
| Compound Name | 4-acetyl-3-methyl-7-[[(4R,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]amino]-1H-naphthalen-2-one |
|---|---|
| PubChem CID | 158052492 |
| Molecular Formula | C19H23NO7 |
| Molecular Weight | 377.39 g/mol |
| Exact Mass | 377.15 |
| IUPAC Name | 4-acetyl-3-methyl-7-[[(4R,5S)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]amino]-1H-naphthalen-2-one |
| SMILES | CC(=O)C1=C(C)C(=O)Cc2cc(NC3C(O)OC(CO)[C@@H](O)[C@@H]3O)ccc21 |
| InChI | InChI=1S/C19H23NO7/c1-8-13(23)6-10-5-11(3-4-12(10)15(8)9(2)22)20-16-18(25)17(24)14(7-21)27-19(16)26/h3-5,14,16-21,24-26H,6-7H2,1-2H3/t14?,16?,17-,18-,19?/m1/s1 |
| InChIKey | FJQOIRXBIAFYIB-IIGXQCEESA-N |
| XLogP | -0.61 |
| TPSA | 136.32 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 377.39 |
| LogP ≤ 5 | -0.61 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158052492 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.